Russell Investments »

Contineum Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $35k 2.1k 16.39
2025-03-31 $2.2k 318 6.98

More positions owned by Russell Investments

Nvidia Corp Common stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Common Stock (GOOG)
Alphabet Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Micron Technology Common Stock (MU)
Taiwan Semiconductor Manufacturing Company Common Stock (TSM)
Meta Platforms Common Stock (META)
Mastercard Incorporated Common Stock (MA)
Advanced Micro Devices Common Stock (AMD)
Eli Lilly And Company Common Stock (LLY)
Tesla Common Stock (TSLA)
Applied Materials Common Stock (AMAT)

View all positions for Russell Investments

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Jupiter Topco
Henderson Group
BlackRock
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Vanguard Capital Management
Perceptive Advisors
FMR
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Longaeva Partners
Ikarian Capital
Sectoral Asset Management

View all funds holding Contineum Therapeutics